We are live on !
Find out more
Anixa Biosciences
ANIX
ANIX
15 hedge funds and large institutions have $789K invested in Anixa Biosciences in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bard Associates
Chicago,
Illinois
|
+$283K |
| 2 |
Millennium Management
New York
|
+$167K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$160K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$51.6K |
| 5 |
Morgan Stanley
New York
|
+$46.5K |
Top Sellers
No sellers this quarter
ANIX Hedge Fund Activity: Q3 2015 in Review
15 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q3 2015, worth a combined $789K.
Buyers outnumbered sellers: 15 funds opened new ANIX positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bard Associates, opening a new position worth an estimated $283K.
- 15 institutional investors held Anixa Biosciences (ANIX) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $789K of Anixa Biosciences stock for Q3 2015.
- 15 funds opened new Anixa Biosciences positions in Q3 2015 and 0 closed out, a net change of +15 holders.
- The largest Anixa Biosciences buyer in Q3 2015 was Bard Associates, an estimated $283K added.
Based on aggregated 13F filings for Q3 2015.